HF
CMPX icon

HRT Financial’s Compass Therapeutics CMPX Stock Holding History

HRT Financial’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Buy
+19,851
New +$115K ﹤0.01% 3347
2025
Q3 		– Sell
-60,778
Closed -$158K – 2951
2025
Q2 		$158K Buy
+60,778
New +$125K ﹤0.01% 2124
2024
Q3 		– Sell
-122,038
Closed -$122K – 2517
2024
Q2 		$122K Buy
+122,038
New +$178K ﹤0.01% 1737

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

HRT Financial's CMPX Position: Q1 2026 in Review

HRT Financial opened a new position in Compass Therapeutics (CMPX) in Q1 2026: 19,851 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #3347 among its holdings. This is a return to the name: HRT Financial previously reported a position in CMPX as recently as Q2 2025.

HRT Financial first reported a position in CMPX in Q2 2024 and has held it in 3 quarters since. The position peaked at $158K in Q2 2025. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • HRT Financial held 19,851 shares of Compass Therapeutics worth $105K as of Q1 2026.
  • Compass Therapeutics was a new HRT Financial position in Q1 2026.
  • Compass Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3347 holding.
  • HRT Financial first reported a position in Compass Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • HRT Financial's Compass Therapeutics position peaked at $158K in Q2 2025.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.